Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Muromonab Chimeric Recombinant Rabbit Monoclonal Antibody (OKT-3 (muromonab))

Rabbit Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA547769

Catalog No. PIMA547769


Only null left
Add to Cart

Description

Description

Specificity: Epitope on the epsilon-subunit within the human CD3 complex.

Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a). Muromonab binds to the T-cell surface glycoprotein CD3 epsilon chain. It appears to kill CD-3 positive cells by inducing Fc mediated apoptosis, antibody mediated cytotoxicity and complement-dependent cytotoxicity.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Muromonab Chimeric
Recombinant Monoclonal
1 mg/mL
PBS with 0.02% ProClin 300
P04235, P11942, P22646, P24161
Human peripheral E+ cells.
200 μg
Primary
Human
Antibody
IgG κ
Flow Cytometry, Immunocytochemistry
OKT-3 (muromonab)
Unconjugated
Cd247
Rabbit
Protein A
RUO
12500, 12501, 12502, 12503
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.